In this issue, I have the pleasure to share an insightful article by Sibyl Bertrand. As a molecular biologist, Sibyl worked in numerous cancer research institutes in France before arriving in the UK where she pursued her PhD in clinical medicine at the University of Oxford, studying mutagenesis mechanism in cancer predisposition and tumour development. Evguenia Alechine (editor)